MedLife S.A. — M&A Activity 2022

Feb 23, 2022

MedLife Group receives the approval of the Competition Council for the acquisition of 50% of Neolife shares

By completing the largest transaction initiated in 2021, MedLife is expanding its oncology facilities nationwide

Bucharest, February 23, 2022 - MedLife has completed the acquisition of a 50% stake in Neolife Romania's oncology centers, following its approval by the Competition Council. It is the largest transaction initiated by MedLife last year.

Thus, MedLife Group consolidates its integrated diagnostic and oncological treatment services through the 4 Neolife medical centers in Bucharest (2), Iași and Brașov that will offer Romanian patients state-ofthe-art technology, international medical know-how provided by multidisciplinary teams, experts in the most advanced procedures of diagnosis and oncological treatment. Moreover, Neolife team has managed to develop excellent services in radiotherapy and nuclear medicine in neighboring countries such as Bulgaria and the Republic of Moldova and, in this context, MedLife Group will expand partnerships that will go beyond Romania's borders.

"MedLife's strategic goal is to strengthen the oncology area through a holistic approach that ranges from cancer prevention, diagnosis and treatment, to ensuring the quality of life of the oncological patient. The advantage will be the unbeatable experience of Neolife to provide access to top personalized medical care", mentioned Mihai Marcu, CEO of MedLife.

"Together with MedLife, we are becoming a benchmark for our approach and effectiveness in treating cancer. Both by expanding the medical infrastructure and increasing the accessibility of cancer patients to top services, but especially by ensuring the long-term quality of Romanian health. We are not in the most optimistic scenario in the oncological area with 95,000 new cancers and about 54,000 cancer deaths in 2021, with the pandemic leading to significant delays in diagnosis and treatment. But even if the expectation is to increase the number of patients diagnosed with cancer or in advanced stages, there is also a leap in research and innovation through which our state-of-the-art therapies provide effective weapons in the fight against cancer. In Romania we have a very well-established team of professionals led by Fabio Razzetto, our Country Manager ", said Ismail Dernek, CEO of MNT Healthcare Group.

Neolife Medical Center Romania, with a total of over 250 employees and collaborators, ended 2021 with a turnover of 110 million RON, increasing by 20% compared to 2020.

MedLife Group will continue its dynamic expansion strategy after acquiring 6 companies last year: CED Pharma (June 2021), Leti Pharm (June 2021), Monix Pharm (June 2021), Pharmachem Distribution (July 2021), which were already consolidated. They were joined in November last year by Neolife Medical Center. Also at the end of last year, the company announced the acquisition of the full shareholding package of OncoCard Hospital in Brasov, acquisition that is still subject to Competition Council approval.

***

About Neolife Medical Center Romania

Present for 7 years on the Romanian market, through 4 medical centers, it is a member company of Bozlu Group from Turkey, which has 21 companies internationally, working in the field of health and technological services for 32 years. Neolife brand's experience in nuclear medicine dates back to 1989 when the first private company to provide such services in a hospital was opened in Turkey. Just one year later, in 1990, the first independent private center was established. Since then, development has been very rapid, and medical diagnostic and cancer treatment services are now provided in more than 60 public and private hospitals in Turkey. https://www.neolife.ro/

About MedLife Medical System

MedLife Medical System started almost three decades ago, has developed healthily and has become the largest provider of private medical services in Romania. Romanian entrepreneurs, who founded this company, invested and got involved to change the Romanian health system, believed in innovation and dared to aim as high as possible, to offer Romanian patients qualitative services, professionalism, care and respect for their needs.

The company operates the largest network of clinics, one of the largest networks of medical laboratories, general and specialized hospitals and has the largest corporate clients base for Health Prevention Packages in the country. It is also one of the largest private healthcare providers in Central and Eastern Europe in terms of sales.

MedLife Group has a history of success in terms of both organic growth and by acquisitions. Strong and experienced management team, was able to create and manage these growth opportunities, gaining valuable knowledge and experience, which allows to find the best way to successfully continue the expansion.

Being a Romanian company with a tradition, MedLife chose to be listed on the Romanian Stock Exchange, being a model for listings on the local capital market. It has opened up new horizons, and through the corporate governance it has implemented, has inspired other local companies to embark on this path and help develop the Romanian capital and economy. The shares issued by MedLife SA are admitted to trading on the regulated spot market administered by the Bucharest Stock Exchange, Premium Category, with the trading symbol ″ M ″.

During the pandemic, MedLife managed to play a key role in society and gain a detached leadership status in pandemic monitoring through active involvement in research activities.

The company continues to invest in projects in technology and infrastructure, with impact on the local community. It creates jobs and develops an ecosystem that contributes to the development and maintenance of a healthy Romania.